Long-term use of finasteride and dutasteride may be linked to health risks like fatty liver disease, insulinresistance, type 2 diabetes, dry eye disease, and potential kidney disease. Some users believe the risks are low and the medications are generally safe.
Male pattern baldness (MPB) may be an early warning sign for type 2 diabetes due to its association with insulinresistance. Treatments discussed include testosterone therapy and finasteride, which affects hormone levels related to hair loss and insulin sensitivity.
The individual is experiencing hair loss due to insulinresistance (IR) and is seeking advice. They are currently using a keto diet, supplements, exercise, and plan to add metformin to their regimen.
A 57-year-old man with male pattern hair loss and insulinresistance experienced hair regrowth and weight loss after using tirzepatide, without other hair treatments. Dysregulated glucose metabolism is linked to hair loss, with tirzepatide potentially improving hair density by normalizing insulinresistance.
Excessive sugar consumption may contribute to male pattern hair loss by increasing androgen sensitivity and insulinresistance, but genetics play a significant role. Treatments like minoxidil and finasteride are suggested for managing hair loss, while reducing sugar intake and maintaining a healthy lifestyle may help mitigate its progression.